Halfpenny Technologies enters into agreement with Janssen Diagnostics to solve interoperability for HIV/AIDS Clinical Data Exchange

BLUE BELL, Pa.--Halfpenny Technologies, Inc. announced today that it has entered into an agreement with Janssen Diagnostics, LLC that will supplement the unique clinical data needs of Janssen’s AVIGA™ EHR. The AVIGA™ electronic health record is uniquely designed to support the data and federal reporting needs of providers specializing in HIV/AIDS healthcare. Halfpenny Technologies has collaborations or strategic partnerships with numerous EHR companies; this agreement, utilizing Halfpenny’s intelligent integration technology hub and its core data normalization competencies supplements the wide range of services AVIGA™ provides its clients.

“Accessing all manners of clinical data in a timely and standardized manner and within the established workflow of the healthcare provider allows for more timely and effective clinical support, essential to delivering better patient care,” Halfpenny Technologies President and CEO, Tim Kowalski said. “By leveraging our single interface, AVIGA supported HIV and AIDS treatment centers funded by the Ryan White CARE Act will be better served and relieved of cumbersome reporting requirements.”

“This is another significant step in the expansion of Halfpenny’s Interoperability Technology Framework Hub (ITF-Hub),” said Kowalski. “Interoperability is the cornerstone of an integrated, effective and efficient healthcare system and to that effect Halfpenny Technologies supports the data needs of multiple participants in the healthcare continuum.” Halfpenny Technologies will be extracting relevant clinical data from EHRs to enhance the data within the AVIGA system.

About Halfpenny Technologies

Halfpenny Technologies Inc. provides clinical laboratories, hospitals, health plans, health information exchanges and EHR vendors with a cloud based, secure, scalable, vendor-neutral clinical data exchange platform. Our proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and LOINC mapping enables laboratories and hospitals to win new clients and better compete in the HITECH era; health plans to improve HEDIS reporting and STAR ratings, increase revenue and support population-based initiatives; and EHR vendors to include CPOE and results delivery in their solutions and meet Meaningful Use certification requirements.

To learn more about Halfpenny Technologies visit the web site: www.halfpenny.com.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.